Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Axonics Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 16, 2023 / 08:05PM GMT
Release Date Price: $53 (-1.89%)
Shagun Singh
RBC Capital Markets - Analyst

Thank you, everyone, for being here today and welcome to the 2023 RBC's Global Healthcare Conference. My name is Shagun Singh. I'm a Senior Medical Device Analyst here at RBC, and I'm very pleased to have our next company here for a fireside chat, which is Axonics.

Joining us from the company are Ray Cohen, Chief Executive Officer, as well as Neil Bhalodkar, Vice President of Investor Relations. Thank you so much for being here today. We really appreciate it.

Ray Cohen
Axonics, Inc. - CEO

Thank you. It's a pleasure to be here. I appreciate you inviting us.

Questions & Answers

Shagun Singh
RBC Capital Markets - Analyst

Great. So I thought we'll begin with a discussion of perhaps Q1, the latest trends and guidance since you just reported numbers. You delivered a pretty strong beat in Q1, and I think it was driven by both your businesses, which is Sacral Neuromodulation, as well as Bulkamid. Can you maybe talk a little bit about monthly trends for each

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot